Stock Earnings

Question 1

WAVE Life Sciences Ltd 的关键财务报表是什么？

Accepted Answer

根据最新的财务报表（Form-10K），WAVE Life Sciences Ltd 的总资产为 $352，净loss为 $-97

Question 2

WVE 的关键财务比率是什么？

Accepted Answer

WAVE Life Sciences Ltd 的流动比率是 2.62，净利 margin 为 -89.81，每股销售为 $0.78。

Question 3

WAVE Life Sciences Ltd 的收入按细分市场或地理位置如何划分？

Accepted Answer

WAVE Life Sciences Ltd largest revenue segment is Stereopure Oligonucleotides, at a revenue of 113,305,000 in the most earnings release.For geography, Singapore, United States, Japan, United Kingdom, and Ireland is the primary market for WAVE Life Sciences Ltd, at a revenue of 113,305,000.

Question 4

WAVE Life Sciences Ltd 是否盈利？

Accepted Answer

no，根据最新的财务报表，WAVE Life Sciences Ltd 的净loss为 $-97

Question 5

WAVE Life Sciences Ltd 有负债吗？

Accepted Answer

yes，WAVE Life Sciences Ltd 的负债为 134

Question 6

WAVE Life Sciences Ltd 的流通股有多少？

Accepted Answer

WAVE Life Sciences Ltd 的总流通股为 153.03

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	93	108	113	3	40	20
Revenue Growth (YoY)	-15%	-4%	3,667%	-93%	100%	33%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	67	59	51	50	46	42
Research & Development	169	159	130	115	121	130
Operating Expenses	237	218	181	166	167	173
Other Non Operating Income (Expenses)	2	3	1	0	4	2
Pretax Income	-129	-97	-58	-161	-122	-150
Income Tax Expense	0	0	0	0	0	0
Net Income	-129	-97	-57	-161	-122	-149
Net Income Growth	77%	70%	-65%	32%	-18%	-23%
Shares Outstanding (Diluted)	163.98	138.27	106.09	78.86	51.83	39.23
Shares Change (YoY)	27%	30%	35%	52%	32%	16%
EPS (Diluted)	-0.79	-0.7	-0.54	-2.05	-2.36	-3.82
EPS Growth	37%	28.99%	-74%	-13%	-38%	-33%
Free Cash Flow	-200	-151	-20	-129	-89	-117
Free Cash Flow Per Share	-1.21	-1.09	-0.18	-1.63	-1.71	-2.98
Gross Margin	--	--	--	--	--	--
Operating Margin	-153.76%	-101.85%	-59.29%	-5,400%	-317.5%	-765%
Profit Margin	-138.7%	-89.81%	-50.44%	-5,366.66%	-305%	-745%
Free Cash Flow Margin	-215.05%	-139.81%	-17.69%	-4,300%	-222.5%	-585%
EBITDA	-140	-107	-62	-156	-120	-145
EBITDA Margin	-150.53%	-99.07%	-54.86%	-5,200%	-300%	-725%
D&A For EBITDA	3	3	5	6	7	8
EBIT	-143	-110	-67	-162	-127	-153
EBIT Margin	-153.76%	-101.85%	-59.29%	-5,400%	-317.5%	-765%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

WAVE Life Sciences Ltd (WVE) Price

WVE Stock Price Chart

WVE Income

Follow-Up Questions